InSimili
PrivateLast Round
Grant
Jun 4, 2025
Total Funding Raised
$226,000
Company Overview
InSimili is a biotechnology company that develops and markets oxygen-regulating microplate technology to improve the drug discovery process by mimicking human physiological conditions in vitro.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InSimili Comparables
Compare InSimili with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Semarion | 79% | |
| SynVivo | 78% | |
| TissUse | 77% |
InSimili Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 4, 2025 | ||||
| Grant | Jan 29, 2025 | ||||
| Seed | Jul 19, 2024 | ||||
| Accelerator | Apr 27, 2021 |
InSimili Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2025
$65K grant received from Tehnopol-EE.
- Jan 29, 2025
$5K grant received from Society for Laboratory Automation and Screening
InSimili Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about InSimili's valuation, stock price, and market status.
Is InSimili a public or private company?
InSimili is a private company.
What is the current stock price of InSimili?
InSimili is a private company with no public stock price. Caplight tracks InSimili's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is InSimili worth (valuation)?
Valuation information for InSimili is not publicly available.
Can I buy InSimili stock?
InSimili shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was InSimili's last funding round?
InSimili's most recent funding round was Grant on June 4, 2025.
Who are the main investors in InSimili?
Key investors in InSimili include Almacube, G-Factor.
Will InSimili IPO soon?
No public IPO plans have been announced for InSimili.
How can I track InSimili secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor InSimili's secondary market activity and sign up for updates.